期刊文献+

良性前列腺增生术后逆行射精的机制及预防措施的研究进展

Research progress on mechanism and preventive measures of retrograde ejaculation after benign prostatic hyperplasia surgery
下载PDF
导出
摘要 良性前列腺增生是中老年男性的常见疾病,一线治疗方式为药物治疗,但随着疾病的进展或药物副作用,外科治疗将成为更佳选择。然而,不论是作为“金标准”术式的经尿道前列腺电切术或是基于各类激光平台或等离子技术的前列腺剜除术,术后随访中均发现逆行射精发生率较高。过去通常将逆行射精视为良性前列腺增生手术的代价,但近年来随着手术方式的不断改良和新技术的涌现,逆行射精问题已经引起临床医生的关注。本文主要对前列腺增生术后逆行射精的发生机制及其预防措施进行综述。这些措施主要包括各类改良术式,以及前列腺栓塞术、前列腺段尿道悬吊术等新颖的微创技术。 Benign prostatic hyperplasia(BPH)is a common disease in middle-aged and elderly men.It's first-line therapy is drugs.But with the progression of the disease or side effects of drugs,surgical treatment will become a better choice.However,either transurethral resection of the prostate,the standard procedure,or enucleation or resection of the prostate based on various laser platforms or plasma technologies cause a high incidence of retrograde ejaculation in their postoperative follow-up.In the past,retrograde ejaculation was usually regarded as the cost of benign prostatic hyperplasia surgery.In recent years,with the continuous improvement of surgical skills and the emergence of new techniques,retrograde ejaculation has aroused the attention of clinicians.This article mainly introduces the mechanism of retrograde ejaculation after benign prostatic hyperplasia surgery and the methods to reduce the incidence of retrograde ejaculation after surgery.These methods mainly include various modified surgery,as well as novel minimally invasive techniques such as prostate embolization and prostatic urethral lift.
作者 杨国荣(综述) 吕凯凯(综述) 吴洋洋(综述) 宋涛(审校) YANG Guo-rong;LKai-kai;WU Yang-yang;SONG Tao(Department of Urology,The Third Medical Center,Chinese PLA General Hospital,Beijing 100039,China;Graduate School,Medical School of Chinese PLA,Beijing 100017,China)
出处 《中华男科学杂志》 CAS CSCD 北大核心 2023年第12期1022-1027,共6页 National Journal of Andrology
基金 国家重点研发计划(2021YFC2009304)
关键词 良性前列腺增生 逆行射精 benign prostatic hyperplasia retrograde ejaculation
  • 相关文献

参考文献10

二级参考文献102

  • 1李程,王永胜,王波,罗家宇,刘利权.前列腺增生经尿道前列腺等离子剜除术治疗的临床观察[J].中国急救医学,2018,38(A01):125-125. 被引量:6
  • 2宋涛,陈文政,张旭.精囊镜技术在泌尿外科的应用[J].微创泌尿外科杂志,2013,2(2):84-87. 被引量:13
  • 3潘铁军,刘波,文瀚东,沈国球,涂忠,钱卫红,杨家荣.保留膀胱颈的前列腺剜除术对性功能的影响及处理[J].微创泌尿外科杂志,2013,2(3):192-194. 被引量:7
  • 4Emberton M, Anson K. Acute urinary retention in men: an age old problem. BMJ 1999; 318: 921-5.
  • 5Jacobsen S.I, ,lacobson D,l, Girman C J, Roberts RO, Rhodes T, et al. Natural history of prostatism: risk factors for acute urinary retention. J Uro11997; 158: 481-7.
  • 6Fitzpatric ,lM. The natural history of benign prostatic hyperplasia. BJU Int 2006; 97: 3-6.
  • 7Fitzpatrick JM, Desgrandchamps F, Adjali K, Gomez Guerra L, Hong S J, et al. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. BJU Int2012; 109: 88-95.
  • 8McNeill SA, Hargreave TB, Members of the AIfaur Study Group. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol 2004; 171: 2316-20.
  • 9Jong HY, Tibung M J, Macalalag M, Li MK, Consigliere D. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia. Urol Int 2009; 83: 44-8.
  • 10Zeif HJ, Subramonian K. Alpha blockers prior to removal of a catheter for acute urinary retention in adult men. Cochrane Database Syst Rev 2009; 4:CD006744.

共引文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部